Summary Primatene Mist inhalers provide temporary relief from mild, intermittent asthma symptoms. They are the only OTC ...

Amphastar's Q2 2024 revenue grew 25% year-over-year to $182.4 million, primarily driven by BAQSIMI and Primatene MIST sales. Primatene MIST faces future challenges as its key patent expires in ...

Walgreens announced that it will shutter 1,200 stores over the next three years — and 500 locations in 2025 alone — as the drugstore giant seeks to slash $1 billion in costs. The Chicago-based ...

Walgreens is closing approximately 1,200 locations as the drug store chain struggles to contend with online competitors and declining prescription drug payments. By 2027, about one in seven ...

Walgreens will close 1,200 stores over the next three years after announcing fourth-quarter earnings on Tuesday that beat analyst expectations, as the pharmacy chain—which reported future ...

Walgreens Boots Alliance plans to close 1,200 stores during the next three years, with 500 closures set for next year, in the face of low drug reimbursement rates and slower consumer spending. The ...

Walgreens plans to close at least 1,200 stores over the next three years as the pharmacy giant seeks to reduce costs and turn around operations under a new leader. One of the largest drugstore ...

A key highlight for the quarter was Primatene MIST which achieved its highest quarterly sales since the launch reaching $26 million in sales. This performance is a significant step toward our goal ...

Walgreens plans to close about 1,200 locations over the next three years as part of a cost-cutting plan, the company said Tuesday. That represents about 9.5 percent of the pharmacy chain’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Our strategic initiatives regarding our regulatory filings and commercial portfolio execution remain on track and we are well positioned to continue the growth of our key revenue drivers with BAQSIMI, ...